Academic medicine leaders from all AAMC affinity groups gathered for our Leadership Forum, “Achieving Diversity, Inclusion, and Equity in Academic Medicine.”
By understanding the factors at play and involving minority groups in solutions, investigators can encourage underrepresented groups to participate in trials.
What happens when standard treatments fail? A young cancer patient’s story shows how both public and private funding are vital to supporting medical research.
Successful advocacy depends on continuous engagement and ongoing relationships, AAMC Chief Public Policy Officer Karen Fisher, JD, writes in a Viewpoint.
